A detailed history of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H transactions in Pfizer Inc stock. As of the latest transaction made, Meag Munich Ergo, Kapitalanlagegesellschaft Mb H holds 2,286,226 shares of PFE stock, worth $61.1 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares
2,286,226
Previous 2,052,326 11.4%
Holding current value
$61.1 Million
Previous $57.4 Million 15.22%
% of portfolio
2.14%
Previous 1.94%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$27.7 - $31.39 $6.48 Million - $7.34 Million
233,900 Added 11.4%
2,286,226 $66.2 Million
Q1 2024

Apr 18, 2024

SELL
$25.89 - $29.73 $699,030 - $802,710
-27,000 Reduced 1.3%
2,052,326 $57 Million
Q4 2023

Jan 19, 2024

BUY
$26.13 - $33.94 $11 Million - $14.3 Million
420,082 Added 25.32%
2,079,326 $59.9 Million
Q3 2023

Oct 25, 2023

BUY
$32.09 - $37.51 $4.56 Million - $5.32 Million
141,957 Added 9.36%
1,659,244 $55 Million
Q2 2023

Jul 14, 2023

BUY
$36.12 - $41.79 $5.09 Million - $5.89 Million
140,882 Added 10.24%
1,517,287 $55.7 Million
Q1 2023

Apr 20, 2023

BUY
$39.39 - $51.28 $11.4 Million - $14.8 Million
288,709 Added 26.54%
1,376,405 $56.2 Million
Q4 2022

Jan 19, 2023

SELL
$41.75 - $54.5 $251,919 - $328,853
-6,034 Reduced 0.55%
1,087,696 $55.7 Million
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $6.32 Million - $7.71 Million
144,348 Added 15.2%
1,093,730 $47.9 Million
Q2 2022

Jul 19, 2022

BUY
$46.53 - $55.17 $11.5 Million - $13.7 Million
247,702 Added 35.3%
949,382 $49.8 Million
Q1 2022

Apr 13, 2022

BUY
$45.75 - $56.69 $7.2 Million - $8.92 Million
157,297 Added 28.89%
701,680 $36.8 Million
Q4 2021

Jan 25, 2022

BUY
$41.32 - $61.25 $22.5 Million - $33.3 Million
544,383 New
544,383 $31.9 Million
Q2 2021

Jul 16, 2021

SELL
$35.91 - $40.68 $897,749 - $1.02 Million
-25,000 Closed
0 $0
Q1 2021

Apr 20, 2021

BUY
$33.49 - $37.77 $837,250 - $944,250
25,000 New
25,000 $906,000
Q4 2020

Jan 20, 2021

SELL
$33.47 - $42.56 $535,520 - $680,960
-16,000 Closed
0 $0
Q3 2020

Oct 20, 2020

BUY
$31.75 - $37.25 $508,000 - $596,000
16,000 New
16,000 $587,000
Q2 2020

Jul 16, 2020

SELL
$30.12 - $36.54 $63,282 - $76,770
-2,101 Closed
0 $0
Q1 2020

Apr 23, 2020

SELL
$27.03 - $38.62 $2.97 Million - $4.25 Million
-109,991 Reduced 98.13%
2,101 $69,000
Q4 2019

Jan 17, 2020

SELL
$32.92 - $37.36 $9.31 Million - $10.6 Million
-282,889 Reduced 71.62%
112,092 $4.36 Million
Q3 2019

Oct 29, 2019

BUY
$32.49 - $42.13 $4.86 Million - $6.3 Million
149,495 Added 60.9%
394,981 $14.2 Million
Q2 2019

Jul 17, 2019

BUY
$36.98 - $41.52 $961,479 - $1.08 Million
26,000 Added 11.85%
245,486 $10.7 Million
Q1 2019

Apr 29, 2019

BUY
$37.5 - $41.2 $8.23 Million - $9.04 Million
219,486 New
219,486 $9.28 Million
Q4 2018

Jan 29, 2019

SELL
$38.47 - $43.86 $17.3 Million - $19.7 Million
-449,505 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$34.47 - $41.81 $4,170 - $5,059
121 Added 0.03%
449,505 $19.6 Million
Q2 2018

Jul 17, 2018

SELL
$32.98 - $35.16 $12.7 Million - $13.6 Million
-386,380 Reduced 46.23%
449,384 $16.5 Million
Q1 2018

May 02, 2018

BUY
$31.91 - $37.02 $5.21 Million - $6.05 Million
163,421 Added 24.31%
835,764 $29.4 Million
Q4 2017

Jan 26, 2018

SELL
$33.26 - $35.29 $3.35 Million - $3.55 Million
-100,730 Reduced 13.03%
672,343 $24.6 Million
Q3 2017

Nov 06, 2017

BUY
$31.0 - $34.15 $24 Million - $26.4 Million
773,073
773,073 $27.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Portfolio

Follow Meag Munich Ergo, Kapitalanlagegesellschaft Mb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.